Tag - dementia

 
 

DEMENTIA

BUSINESS / Markets
Nov 29, 2022
Eisai and Biogen plunge after report of second death in Alzheimer’s trial
The case involved a 65-year-old woman who died of a massive brain hemorrhage after suffering a stroke and a type of brain swelling and bleeding in an Eisai trial, a report said.
Japan Times
COMMENTARY / World
Oct 4, 2022
New Alzheimer's drug from Biogen and Eisai is just the beginning
A successful late-stage trial of lecanemab gives researchers promising new avenues for tackling this hard-to-beat disease.
Japan Times
WORLD / Science & Health / ANALYSIS
Sep 30, 2022
Eisai drug's trial success raises hope for Alzheimer's prevention
Scientists have already begun to debate whether the benefit of the drug is robust enough, but to many researchers, the findings suggest that preventing decline altogether is possible.
Japan Times
JAPAN / Science & Health
Sep 28, 2022
Alzheimer’s progression slowed by drug in major trial
The drug slowed cognitive decline in people with early Alzheimer's by 27% over 18 months when compared with a placebo using a common rating scale.
Japan Times
BUSINESS / Companies
Jul 6, 2022
Eisai says Alzheimer’s drug will get priority review in U.S.
Under the accelerated approval pathway, drugs can be approved based on their ability to remove amyloid, a hallmark of the disease, from the brain.
Japan Times
BUSINESS
Apr 9, 2022
Japan's Eisai still seeking accelerated U.S. review of Alzheimer's drug
The firm said it plans to seek a quick approval even after the Medicare health plan decided to limit coverage of medicines approved in that manner.
Japan Times
JAPAN / Society
Feb 3, 2022
In Japan, a thousand digital eyes keep watch over the elderly
The surveillance programs offer the promise of protecting those in cognitive decline while helping them retain some independence, but they have also evoked fears of authoritarian overreach.
Japan Times
WORLD / Science & Health
Jul 29, 2021
Doctors blast Biogen Alzheimer approval as ‘regulatory failure’
The New England Journal of Medicine opinion piece is another sign of persistent furor over the agency's decision.
Japan Times
BUSINESS / Companies
Jul 13, 2021
Eisai pushes second Alzheimer's drug despite call to probe U.S. approval of first
The U.S. Food and Drug Administration's June approval of Aduhelm caused resignations among a panel of independent experts who said the therapy was ineffective.
Japan Times
JAPAN / Science & Health
Jun 8, 2021
Changing the game for Alzheimer's treatment, U.S. approves Eisai and Biogen's drug
The approval appears to signal a fundamental shift in the way the FDA thinks about Alzheimer's disease, which could have lasting ramifications for other drugs in the pipeline.
Japan Times
JAPAN / Society
Jul 15, 2020
Japan FSA seeks improved support to manage older people's finances
Japan's Financial Services Agency on Wednesday called for financial institutions to improve their support for older people who have difficulties with financial transactions due to deteriorating cognitive abilities.
Japan Times
BUSINESS
Dec 6, 2019
Biogen builds case for its Alzheimer's drug, but skeptics say more data needed
Biogen Inc. laid out more data Thursday on its experimental Alzheimer's drug, raising no major safety alarms but also offering little compelling evidence that the drug, once declared a failure, actually works.
JAPAN / Science & Health
Nov 6, 2019
Japanese researchers pave way for early diagnosis of Alzheimer's using blood test
A team of researchers from Nagoya City University and other institutions have discovered a method that may pave the way for early diagnosis of Alzheimer's disease using a blood test.
Japan Times
BUSINESS
Oct 23, 2019
Biogen and Eisai revive plans for Alzheimer's drug aducanumab, but prospects still shaky
Biogen Inc. revived plans on Tuesday to seek U.S. approval for the Alzheimer's treatment aducanumab and said data from more patients in two discontinued studies showed the drug reduced the decline of patients.
WORLD / Science & Health
Jul 4, 2019
For some dementia patients in California, 'man's best friend' is a robot dog
A robot dog under development in California is vying to be a best friend to people with Alzheimer's disease and other forms of dementia, offering comfort by responding to human touch with life-like motions.
Japan Times
JAPAN / Media / BIG IN JAPAN
Jun 29, 2019
As dementia cases rise, so a nation's character changes
"Your mother is senile, senile, senile!"
JAPAN
Jun 20, 2019
After record 16,927 dementia patients went missing in Japan in 2018, expert urges community support
Of the nearly 17,000 people who wandered off in 2018, 197 could not be found by the end of the year, according to police data.
Japan Times
CULTURE / Film
May 29, 2019
'A Long Goodbye': Taking a lighter look at Alzheimer's
Japanese films about dementia are by now many and, given demographic trends here, interest in the subject is both natural and necessary.
Japan Times
JAPAN / Science & Health
May 29, 2019
Blood test can predict dementia, but Japanese developers urge caution: There's still no cure
Nobel Prize winner Koichi Tanaka says the predictive blood test for Alzheimer's disease he and colleagues spent almost a decade developing is a double-edged sword.
EDITORIALS
May 25, 2019
Addressing dementia prevention
In looking for ways to prevent dementia, it's important not to blame those who already suffer from it.

Longform

Tetsuzo Shiraishi, speaking at The Center of the Tokyo Raids and War Damage, uses a thermos to explain how he experienced the U.S. firebombing of March 1945, when he was just 7 years old.
From ashes to high-rises: A survivor’s account of Tokyo’s postwar past